Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall BD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall BDsee related information
Date Initiated by FirmSeptember 12, 2024
Date PostedOctober 08, 2024
Recall Status1 Open3, Classified
Recall NumberZ-0026-2025
Recall Event ID 95394
Product Classification Calculator/data processing module, for clinical use - Product Code JQP
ProductBD Synapsys Informatics Solution with software versions: 4.20, 4.30, 5.10, 5.20 and 5.30- IVD standalone laboratory software solution providing data management and workflow management functionality across locations where clinical diagnostic activities take place. Catalog Number: 444150
Code Information UDI-DI: 00382904441500 Software versions: 4.20, 4.30, 5.10, 5.20 and 5.30
FEI Number 1119779
Recalling Firm/
Manufacturer		 Becton Dickinson & Co.
7 Loveton Cir
Sparks MD 21152-9212
For Additional Information ContactSAME
410-316-4000
Manufacturer Reason
for Recall		Synapsys software versions 4.20, 4.30, 5.10, 5.20, or 5.30 and utilizing the in-line breakpoint feature, an error is occurring where BD Synapsys will incorrectly display breakpoints for organisms that do not have defined breakpoints in CLSI or EUCAST. This occurs when the identified organism is included in the same interpretive group as a species for which there is a specific breakpoint. May result in either a false susceptible or false resistant result. A false susceptible result can cause inadequate or incomplete antibiotic treatment due to the use of an ineffective antibiotic, and a false resistant result may limit access to a preferred antibiotic regimen with possible elongation of therapy
FDA Determined
Cause 2		Under Investigation by firm
ActionBD issued Urgent Medical Device Correction letter on 12Sep2024. Letter states reason for recall, health risk and action to take: 1.Immediately identify if you have the affected software version noted in the affected product tableabove. Reference Attachment 2 for software version verification instructions. 2.Determine if the feature is active in your system by reviewing the system settings. Refer toAttachment 3 for System settings breakpoint feature instructions. 3.If the inline breakpoint feature is enabled, please disable the feature and keep disabled untilupgraded to Synapsys" software versions 5.31 or later. Refer to Attachment 3 for Systemsettings breakpoint feature instructions. 4.Ensure the contents of this notification are read and understood. 5.Share and post this customer letter within your facility network and forward to any customers to whom you may have distributed the product to ensure awareness. 6.Complete the attached Customer Response Form and return to the BD contact noted on the form whether or not you have any of the affected software versions, so that BD may acknowledge your receipt of this notification per FDA requirements. Actions taken by BD 1.BD has identified the root cause and is taking action to prevent recurrence of this product issue. 2.BD has resolved the issue in software versions 5.31 and later. If you require further assistance, please contact: BD Contact US Contact Information Areas of Support North American Regional Complaint Center Phone: 1-844-8BD-LIFE (1-844-823-5433) Say Complaints when prompted Mon Fri 8:00am and 5:00pm CT or Email: productcomplaints@bd.com
Quantity in Commerce162 units
DistributionNationwide Foreign: Australia, New Zealand, Singapore, Hong Kong, Taiwan, Japan, Austria, Belgium, Denmark, France, Germany, Italy, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom, Russia, Saudi Arabia, South Africa, Canada, Mexico, China
Total Product Life CycleTPLC Device Report
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
-
-